Common early side effects include nausea, vomiting, diarrhoea, and reduced appetite, consistent with the GLP-1 receptor agonist class
The rising incidences of diabetes and obesity as well as other associated diseases such as cardiovascular diseases due to unhealthy and sedentary lifestyles, rapid urbanization, aging population and hereditary factors are driving the demand for advanced treatment and management solutions which are readily available at hospitals
If GLP-1-related nausea is worst in the morning, consider taking with your largest meal of the day instead of your first.*
My blood pressure medication got cut in half
Critically he showed how insulin gets transported and matures with molecular precision
The Chinese pharmaceutical company Sciwind Biosciences developed ecnoglutide, and has filed for the drugs approval in China for treatment of type 2 diabetes and obesity